Acute fibrinous and organizing pneumonia after bone marrow transplantation, an underrecognized, severe condition

Read full text
Authors: Anita Cassoli Cortez, Maria Cristina Nunez Seiwald, Ana Rita Da Fonseca, Aliana Meneses Ferreira, Gabriella F Pogorzelski, Leonardo Abreu Testagrossa, Yana Augusta Sarkis Novis, André Nathan Costa
Cited by: 0
References: 12

Abstract

INTRODUCTION: Allogeneic bone marrow transplantation can lead to various pulmonary complications, including acute fibrinous organizing pneumonia. This condition is rare and presents with aggressive clinical features, distinct from other forms of organizing pneumonia, such as cryptogenic organizing pneumonia. METHOD: A literature review using the PubMed, Embase, Lilacs, and Cochrane databases was conducted to analyze cases of acute fibrinous organizing pneumonia following transplantation focusing on clinical features, therapeutic approaches, and outcomes. CASE REPORT: The case of a 62-year-old female who developed acute fibrinous organizing pneumonia after transplantation for acute myeloid leukemia is presented. Despite an initial absence of infectious agents, parainfluenza virus was later identified in a bronchoalveolar lavage. The patient progressed to severe hypoxemic respiratory failure and was unresponsive to corticosteroids and rituximab, ultimately dying seven months post-transplant. CONCLUSION: This is a rare and severe complication following allogeneic bone marrow transplantation. Early diagnosis, histopathological confirmation, and prompt initiation of corticosteroid therapy are critical for improving outcomes. Patients diagnosed before Day +100 generally have a better response to treatment and more favorable clinical outcomes. The need for a more effective and targeted treatment strategy remains an unmet challenge in managing this condition.

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Hematopoietic Stem Cell Transplantation Transplantation: Methods and Outcomes

Publication details

Journal / source
Hematology Transfusion and Cell Therapy
Volume
48
Issue
2
Pages
106238–106238
Publication date
10 January 2026
Language
EN